Pacific Radiance Future Growth
Future criteria checks 2/6
Pacific Radiance's earnings are forecast to decline at 84.7% per annum while its annual revenue is expected to grow at 22.4% per year.
Key information
-84.7%
Earnings growth rate
n/a
EPS growth rate
| Energy Services earnings growth | 14.6% |
| Revenue growth rate | 22.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 27 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Investors Appear Satisfied With Pacific Radiance Ltd.'s (SGX:RXS) Prospects As Shares Rocket 33%
Oct 09
Why Investors Shouldn't Be Surprised By Pacific Radiance Ltd.'s (SGX:RXS) 29% Share Price Surge
Aug 13Pacific Radiance Ltd. (SGX:RXS) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jun 03Pacific Radiance's (SGX:RXS) Weak Earnings Might Be Worse Than They Appear
Apr 22Even With A 30% Surge, Cautious Investors Are Not Rewarding Pacific Radiance Ltd.'s (SGX:RXS) Performance Completely
Mar 11Investors Don't See Light At End Of Pacific Radiance Ltd.'s (SGX:RXS) Tunnel And Push Stock Down 27%
Nov 27Why Pacific Radiance's (SGX:RXS) Healthy Earnings Aren’t As Good As They Seem
Nov 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 46 | 6 | N/A | 4 | 1 |
| 12/31/2024 | 34 | 14 | N/A | 15 | 1 |
| 6/30/2024 | 34 | 27 | 2 | 21 | N/A |
| 3/31/2024 | 33 | 20 | -2 | 10 | N/A |
| 12/31/2023 | 31 | 15 | 4 | 9 | N/A |
| 9/30/2023 | 32 | 4 | 5 | 6 | N/A |
| 6/30/2023 | 31 | 307 | 11 | 11 | N/A |
| 3/31/2023 | 34 | 307 | 11 | 11 | N/A |
| 12/31/2022 | 30 | 325 | 1 | 2 | N/A |
| 9/30/2022 | 24 | 324 | 4 | 4 | N/A |
| 6/30/2022 | 19 | 16 | -4 | -4 | N/A |
| 3/31/2022 | 12 | 12 | 0 | -1 | N/A |
| 12/31/2021 | 10 | 1 | 6 | 6 | N/A |
| 9/30/2021 | -33 | 16 | 11 | 10 | N/A |
| 6/30/2021 | -18 | 6 | 7 | 8 | N/A |
| 3/31/2021 | -5 | 1 | 8 | 9 | N/A |
| 12/31/2020 | 9 | -6 | 6 | 7 | N/A |
| 9/30/2020 | 71 | -76 | 6 | 6 | N/A |
| 6/30/2020 | 71 | -75 | 11 | 11 | N/A |
| 3/31/2020 | 76 | -78 | 7 | 8 | N/A |
| 12/31/2019 | 75 | -85 | -1 | 0 | N/A |
| 9/30/2019 | 69 | -103 | -6 | -2 | N/A |
| 6/30/2019 | 69 | -96 | -12 | -9 | N/A |
| 3/31/2019 | 65 | -91 | -11 | -9 | N/A |
| 12/31/2018 | 61 | -99 | -10 | -9 | N/A |
| 9/30/2018 | 65 | -320 | -12 | -10 | N/A |
| 6/30/2018 | 64 | -329 | -9 | -8 | N/A |
| 3/31/2018 | 65 | -331 | N/A | -16 | N/A |
| 12/31/2017 | 68 | -333 | N/A | -23 | N/A |
| 9/30/2017 | 61 | -72 | N/A | -32 | N/A |
| 6/30/2017 | 63 | -77 | N/A | -42 | N/A |
| 3/31/2017 | 65 | -127 | N/A | -43 | N/A |
| 12/31/2016 | 69 | -119 | N/A | -45 | N/A |
| 9/30/2016 | 79 | -85 | N/A | -53 | N/A |
| 6/30/2016 | 94 | -65 | N/A | -35 | N/A |
| 3/31/2016 | 109 | -5 | N/A | -23 | N/A |
| 12/31/2015 | 122 | 4 | N/A | 19 | N/A |
| 9/30/2015 | 137 | 11 | N/A | 67 | N/A |
| 6/30/2015 | 148 | 23 | N/A | 68 | N/A |
| 3/31/2015 | 162 | 53 | N/A | 87 | N/A |
| 12/31/2014 | 172 | 68 | N/A | 62 | N/A |
| 9/30/2014 | 177 | 80 | N/A | 62 | N/A |
| 6/30/2014 | 182 | 77 | N/A | 34 | N/A |
| 3/31/2014 | 179 | 66 | N/A | 34 | N/A |
| 12/31/2013 | 169 | 57 | N/A | 29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RXS's earnings are forecast to decline over the next 3 years (-84.7% per year).
Earnings vs Market: RXS's earnings are forecast to decline over the next 3 years (-84.7% per year).
High Growth Earnings: RXS's earnings are forecast to decline over the next 3 years.
Revenue vs Market: RXS's revenue (22.4% per year) is forecast to grow faster than the SG market (3.8% per year).
High Growth Revenue: RXS's revenue (22.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RXS's Return on Equity is forecast to be high in 3 years time